OSLO — Norway’s $1.4 trillion wealth fund has divested from Chinese pharmaceutical firm Yunnan Baiyao , saying the decision was because the company uses and sells body parts from pangolins, an endangered species. Read More
Advertisements
Daily Digest Signup
Daily business and market business news, business management tips, market research insights, and more.
Advertisements
